The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Evolution of the neuropathology of Alzheimer's disease
Abstract
Our knowledge of the etiology and pathogenesis of Alzheimer's disease is limited. The most conspicuous changes seen in the brain are deposits of insoluble proteins in both extracellular and intraneuronal locations. The extracellular deposits consist primarily of a specific A4 amyloid protein. The significance of these deposits remains to be determined, as they are often found in the cerebral cortex of non-demented elderly persons. More telling is the gradual accumulation of insoluble fibrous material within some neurons that consists mainly of abnormally phosphorylated tau protein. Six stages of increasingly severe cortical destruction can be distinguished. Stages I and II are characterized by neurofibrillary changes that are largely confined to the transentorhinal region, whereas stages III and IV are marked by severe involvement of both the entorhinal and transentorhinal regions. Isocortical destruction occurs during stages V and VI. This progression in cortical pathology correlates with the gradual worsening of clinical symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We focused our analysis on the HIC and associated cortices because these structures are known to be affected early in AD26.”
From Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man (2023) · cites this paper as [26]
In the citing paper
“The hippocampus is not, however, a unitary anatomical formation. Several subfields have been identified, which can be differentiated on both histological grounds [2], [8] and according to their functional role in memory encoding and retrieval [9], [10].”
From Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease (2015) · cites this paper as [2]
In the citing paper
“Neuropathological changes in patients with Alzheimer's disease (AD) typically affect the hippocampal formation very early [1], [2].”
From Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease (2015) · cites this paper as [2]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citationDistributed hierarchical processing in the primate cerebral cortex
Felleman, D. J., & Van Essen, D. C. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.1 · Cited by 7,783
Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans.
Squire, L. R. (1992) · Psychological Review · doi:10.1037/0033-295x.99.2.195 · Cited by 5,376
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Preface: Cerebral Cortex Has Come of Age
Goldman, P. S., & RAKIC, P. T. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.1-a · Cited by 3,537
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Self-citationAlzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Functional Assessment Staging (FAST)
Gauthier, S. G. (2001) · CRC Press eBooks · doi:10.3109/9780203213896-33 · Cited by 1,023
Research works printed but not linked: 2
- Kemper, 1978, Senile dementia: a biomedical approach, 105
- Braak, 1993, Alzheimer's disease: advances in clinical and basic research. Third International Conference on Alzheimer's Disease and Related Disorders, 131
Cited by
Sorted by citations
Items 301–400 of 710
Parkin Promotes Degradation of the Mitochondrial Pro-Apoptotic ARTS Protein
Kemeny, S., Dery, D., Loboda, Y., Rovner, M., Lev, T., Zuri, D., Finberg, J. P. M., & Larisch, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038837 · Cited by 37
Juszczak, L. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309971200 · Cited by 37
Altered Parietal-Motor Connections in Alzheimer's Disease Patients
Bonnı̀, S., Lupo, F., Gerfo, E. L., Martorana, A., Perri, R., Caltagirone, C., & Koch, G. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121144 · Cited by 39
Alzheimer's disease and implicit memory
Machado, S. E. D. C., da Cunha, M. M., Minc, D., Portella, C. E., Velasques, B., Basile, L., Cagy, M., Piedade, R. A. M., & Ribeiro, P. F. M. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000200034 · Cited by 35
Jacini, F., Sorrentino, P., Lardone, A., Rucco, R., Baselice, F., Cavaliere, C., Aiello, M., Orsini, M., Iavarone, A., Manzo, V., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00400 · Cited by 33
Generation of Transgenic Cynomolgus Monkeys Overexpressing the Gene for Amyloid-β Precursor Protein
Seita, Y., Morimura, T., Watanabe, N., Iwatani, C., Tsuchiya, H., Nakamura, S., Suzuki, T., Yanagisawa, D., Tsukiyama, T., Nakaya, M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191081 · Cited by 36
Longitudinal Changes During Aging Using Proton Magnetic Resonance Spectroscopy
Ross, A. J., Sachdev, P. S., Wen, W., & Brodaty, H. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.3.291 · Cited by 35
Severe degenerative cortical and cerebellar atrophy and progressive dementia in a young adult
Markowitsch, H. J., Kessler, J., Schramm, U., & Frölich, L. (2000) · Neurocase · doi:10.1080/13554790008402783 · Cited by 35
Brassen, S., Braus, D. F., Weber-Fahr, W., Tost, H., Moritz, S., & Adler, G. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080028 · Cited by 43
Hornberger, J. C., Bae, J. P., Watson, I., Johnston, J., & Happich, M. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1277197 · Cited by 35
Integrating Sleep and Alzheimer’s Disease Pathophysiology: Hints for Sleep Disorders Management
Proserpio, P., Arnaldi, D., Nobili, F. M., & Nobili, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180041 · Cited by 34
Lewczuk, P., Lelental, N., Lachmann, I., Holzer, M., Flach, K., Brandner, S., Engelborghs, S., Teunissen, C. E., Zetterberg, H., Molinuevo, J. L., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160448 · Cited by 33
Jeong, J., Yum, K. S., Chang, J. Y., Kim, M., Ahn, J. Y., Kim, S., Lapchak, P. A., & Han, M. (2015) · BMC Neurology · doi:10.1186/s12883-015-0390-5 · Cited by 33
Serino, S., & Riva, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00033 · Cited by 34
Jamasbi, E., Separovic, F., Hossain, M. A., & Ciccotosto, G. D. (2017) · Molecular BioSystems · doi:10.1039/c7mb00249a · Cited by 33
Yan, X., Xiong, K., Luo, X., Struble, R. G., & Clough, R. W. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21239 · Cited by 31
Wu, L., Sluiter, A. A., Guo, H., Balesar, R. A., Swaab, D. F., Zhou, J., & Verwer, R. W. H. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00203.x · Cited by 32
Stricker, N. H., Salat, D. H., Foley, J. M., Zink, T. A., Kellison, I. L., McFarland, C. P., Grande, L. J., McGlinchey, R. E., Milberg, W., & Leritz, E. C. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617713000660 · Cited by 33
Fletcher, E. M., Villeneuve, S., Maillard, P., Harvey, D. J., Reed, B., Jagust, W. J., & DeCarli, C. S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.01.133 · Cited by 35
Do angiotensin receptor blockers prevent Alzheimer's disease?
Hajjar, I. M., & Rodgers, K. E. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283620745 · Cited by 35
Fjell, A. M., Amlien, I. K., Westlye, L. T., Stenset, V. T. V., Fladby, T., Skinningsrud, A., Eilsertsen, D. E., Bjørnerud, A., & Walhovd, K. B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.09.029 · Cited by 32
Chukwu, J. E., Pedersen, J. T., Pedersen, L. Ø., Volbracht, C., Sigurdsson, E. M., & Kong, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-24276-4 · Cited by 32
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders
Gupta, S. N., Verma, S., Mantri, S. S., Berman, N. E. J., & Sandhir, R. (2015) · Drug Development Research · doi:10.1002/ddr.21277 · Cited by 31
Zhang, X., Xiong, K., Cai, Y., Cai, H., Luo, X., Feng, J., Clough, R. W., Patrylo, P. R., Struble, R. G., & Yan, X. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07103.x · Cited by 31
Yamasaki, T., Horie, S., Ohyagi, Y., Tanaka, E., Nakamura, N., Goto, Y., Kanba, S., Kira, J., & Tobimatsu, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150939 · Cited by 31
A dynamical systems approach for multiscale synthesis of Alzheimer’s pathogenesis
Rollo, J. L., Crawford, J. W., & Hardy, J. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.018 · Cited by 31
Novel strategies for Alzheimer's disease treatment
Spencer, B. J., Rockenstein, E. M., Crews, L. A., Marr, R. A., & Masliah, E. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.12.1853 · Cited by 31
An MRI substudy of a donepezil clinical trial in mild cognitive impairment
Schuff, N. W., Suhy, J., GOLDMAN, R. S., Xu, Y., Sun, Y., Truran‐Sacrey, D., & Murthy, A. K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.005 · Cited by 30
Zuo, M., Xu, Y., Zhang, X., Li, M., Jia, X., Niu, J., Li, D., Han, Y., & Yang, Y. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2018.01177 · Cited by 30
Fully automated structural MRI of the brain in clinical dementia workup
Persson, K., Selbæk, G., Brækhus, A., Beyer, M. K., Barca, M. L., & Engedal, K. (2016) · Acta Radiologica · doi:10.1177/0284185116669874 · Cited by 30
Brain effective connectivity modeling for alzheimer's disease by sparse gaussian bayesian network
Huang, S., Li, J., Ye, J., Fleisher, A., Chen, K., Wu, T., & Reiman, E. M. (2011) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/2020408.2020562 · Cited by 29
Iyaswamy, A., Krishnamoorthi, S., Liu, Y. W., Song, J., Kammala, A. K., Sreenivasmurthy, S. G., Malampati, S., Tong, B. C., Selvarasu, K., Cheung, K., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.584770 · Cited by 29
Lazarov, O., Peterson, L. D., Peterson, D. A., & Sisodia, S. S. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3961-05.2006 · Cited by 28
Increased hippocampal quinone reductase 2 in Alzheimer's disease
Hashimoto, T., & Nakai, M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.008 · Cited by 29
Suthana, N., Krupa, A. K., Donix, M., Burggren, A. C., Ekstrom, A. D., Jones, M., Ercoli, L. M., Miller, K. J., Siddarth, P., Small, G. W., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.014 · Cited by 30
THA Improves Word Priming and Clonidine Enhances Fluency and Working Memory in Alzheimer's Disease
Riekkinen, P. J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00093-1 · Cited by 29
SUZUKI, W. A., & Porteros, Á. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10370 · Cited by 29
Vemuri, P., Weigand, S. D., Knopman, D. S., Kantarci, K., Boeve, B. F., Petersen, R. C., & Jack, C. R. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.004 · Cited by 28
Mammillary Bodies in Alzheimer’s Disease
Balogiannis, S., Mavroudis, I. A., Baloyannis, I. S., & Costa, V. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515602548 · Cited by 29
Teravskis, P. J., Ashe, K. H., & Liao, D. (2020) · The Neuroscientist · doi:10.1177/1073858420916696 · Cited by 31
Association Between Serum Vitamins and the Risk of Alzheimer’s Disease in Chinese Population
Liu, X., Wu, P.-F., Liu, Y., Jiang, Y., Wan, M., Xiao, X., Yang, Q., Jiao, B., Liao, X., Wang, J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215104 · Cited by 28
Wang, Q., Chen, B., Zhong, X., Hou, L., Zhang, M., Yang, M., Wu, Z., Chen, X., Mai, N., Zhou, H., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01066-9 · Cited by 31
Caudle, W. M., Pan, S., Shi, M. Y., Quinn, T. J., Hoekstra, J. G., Beyer, R. P., Montine, T. J., & Zhang, J. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800043 · Cited by 26
Papadatos, Z., & Phillips, N. A. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.04.001 · Cited by 27
Aß Pathology and Neuron–Glia Interactions: A Synaptocentric View
Huffels, C. F. M., Middeldorp, J., & Hol, E. M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03699-6 · Cited by 29
Brain Networks Reorganization During Maturation and Healthy Aging-Emphases for Resilience
González‐Escamilla, G., Muthuraman, M., Chirumamilla, V. C., Vogt, J., & Groppa, S. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00601 · Cited by 28
Disturbed visual processing contributes to impaired reading in Alzheimer's disease
Glosser, G. (2002) · Neuropsychologia · doi:10.1016/s0028-3932(01)00165-8 · Cited by 27
Verwer, R. W. H., Jansen, K. A., Sluiter, A. A., Pool, C. W., Kamphorst, W., & Swaab, D. F. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7385 · Cited by 28
MOSTAFA, M., Disouky, A., & Lazarov, O. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00580 · Cited by 31
The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain
Gavı́n, R., Lidón, L., Ferrer, I., & del Rı́o, J. A. (2020) · Cells · doi:10.3390/cells9030591 · Cited by 25
Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
Sordo, L., Martini, A. C., Houston, E. F., Head, E., & Gunn-Moore, D. A. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.684607 · Cited by 26
Yun, H. J., Kwak, K., Lee, J., & Initiative, A. D. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129250 · Cited by 26
Li, X., Jiao, J., Shimizu, S., Jibiki, I., Watanabe, K., & Kubota, T. (2012) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12002 · Cited by 26
A neuropsychological study of patients with temporal lobe epilepsy and chronic interictal psychosis
Flügel, D., O’Toole, A., Thompson, P. J., Koepp, M. J., Cercignani, M., Symms, M. R., & Foong, J. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.05.018 · Cited by 26
The Effect of MAPT H1 and APOE ε4 on Transition from Mild Cognitive Impairment to Dementia
Samaranch, L., Cervantes, S., Barabash, A., Alonso, Á., Cabranes, J. A., Lamet, I., Ancín, I., Lorenzo, E., Martínez‐Lage, P., Marcos, A., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101011 · Cited by 27
Jović, M., Lončarević‐Vasiljković, N., Ivković, S., Dinić, J., Milanović, D., Zloković, B. V., & Kanazir, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216726 · Cited by 27
Cortical and subcortical diseases: Do true neuropsychological differences exist?☆
Arango‐Lasprilla, J. C., Rogers, H. L., Lengenfelder, J., DeLuca, J., MORENO, S., & LOPERA, F. (2005) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2005.07.004 · Cited by 26
Lesuis, S. L., van Hoek, B. A. C. E., Lucassen, P. J., & Krugers, H. J. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.05.016 · Cited by 27
Nesteruk, M., Nesteruk, T., Styczyńska, M., Barczak, A. K., Mandecka, M., Walecki, J. M., & Barcikowska, M. (2015) · Neurologia i Neurochirurgia Polska · doi:10.1016/j.pjnns.2015.09.003 · Cited by 25
Pre-dementia Memory Impairment is Associated with White Matter Tract Affection
Grambaitė, R., Reinvang, I., Selnes, P., Fjell, A. M., Walhovd, K. B., Stenset, V. T. V., & Fladby, T. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617710001360 · Cited by 24
Osone, A., Arai, R., Hakamada, R., & Shimoda, K. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12292 · Cited by 24
Genetic Association of HLA Gene Variants with MRI Brain Structure in Alzheimer’s Disease
Initiative, A. D. N., Wang, Z., Wan, Y., Tan, L., Liu, J., Wang, H.-F., Sun, F.-R., Tan, C., Tan, C.-C., Jiang, T., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9889-z · Cited by 24
Neural Correlates of Stroop Performance in Alzheimer’s Disease: A FDG-PET Study
Yun, J., Lee, D. Y., Seo, E. H., Choo, I. H., Park, S. Y., Kim, S. G., & Woo, J. I. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000329517 · Cited by 27
Adenosine Receptors in Neuroinflammation and Neurodegeneration
Salmaso, V., Menin, S., Moro, S., Spalluto, G., & Federico, S. (2025) · Cells · doi:10.3390/cells14201585 · Cited by 25
Neurodegeneration risk factor, EIF2AK3 (PERK), influences tau protein aggregation
Park, G., Xu, K., Chea, L., Kim, K., Safarta, L. A., Song, K., Wu, J., Park, S., Min, H., Hiramatsu, N., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102821 · Cited by 25
Rubial-Álvarez, S., de Sola, S., Machado, M.-C., Sintas, E., Böhm, P., Sánchez‐Benavides, G., Langohr, K., Múñiz, R., & Peña‐Casanova, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121123 · Cited by 23
Rubin, K., & Glazer, S. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.09.017 · Cited by 22
Multimodal Connectomics in Psychiatry: Bridging Scales From Micro to Macro
Scholtens, L. H., & van den Heuvel, M. P. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.03.017 · Cited by 24
Targeting Cell Death in Dementia
Francis, P. T. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213803.82058.46 · Cited by 22
Hippocampal Plasticity in Alzheimer's Disease
Mikkonen, M., Soininen, H. S., Alafuzoff, I., & Miettinen, R. A. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.4.311 · Cited by 24
Small, S. A. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307000-00007 · Cited by 23
Plasticity of human microglia and brain perivascular macrophages in aging and Alzheimer’s disease
Lee, D., Vicari, J. M., Porras, C., Spencer, C., Pjanic, M., Wang, X., Kinrot, S., Weiler, P., Kosoy, R., Bendl, J. M., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02716-6 · Cited by 32
Lee, J. H., Byun, M. S., Sohn, B. K., Choe, Y. M., Yi, D., Han, J. Y., Choi, H. J., Baek, H., Woo, J. I., & Lee, D. Y. (2015) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988715573533 · Cited by 22
Seo, H. J., Park, J. E., Choi, S., Kim, T., Cho, S. H., Lee, K., Song, W. K., Song, J., Jeong, H., Kim, D. H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020698 · Cited by 22
Love, M. C. N., & Ruff, G. (2016) · Medical & Clinical Reviews · doi:10.21767/2471-299x.1000006 · Cited by 21
Pandya, S., Initiative, A. D. N., Kuceyeski, A. F., & Raj, A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160090 · Cited by 24
Yeboah, F., Kim, T., Bill, A., & Dettmer, U. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104543 · Cited by 22
Interaction between Cognitive Reserve and Biomarkers in Alzheimer Disease
Carapelle, E., Mundi, C., Cassano, T., & Avolio, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176279 · Cited by 22
Marson, F., Lasaponara, S., & Cavallo, M. (2021) · Medicina · doi:10.3390/medicina57030215 · Cited by 25
Raj, A. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0905 · Cited by 21
Tau Protein Detection in Anosmic Alzheimer’s Disease Patient’s Nasal Secretions
Passàli, G. C., Politi, L., Crisanti, A., Loglisci, M., Anzivino, R., & Passàli, D. (2015) · Chemosensory Perception · doi:10.1007/s12078-015-9198-3 · Cited by 23
MR Spectroscopy for Assessment of Memantine Treatment in Mild to Moderate Alzheimer Dementia
Ashford, J. W., Adamson, M. M., Beale, T., La, D., Hernandez, B., Noda, A. M., Rosen, A. C., O'Hara, R. M., Fairchild, J. K., Spielman, D. M., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0021 · Cited by 22
Zhang, G., Shen, Y., Phipps, J., Sun, L., & Ma, S. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216059 · Cited by 21
Common Microscale and Macroscale Principles of Connectivity in the Human Brain
Scholtens, L. H., Pijnenburg, R., de Lange, S. C., Huitinga, I., van den Heuvel, M. P., & (NBB), N. B. B. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.1572-21.2022 · Cited by 26
Hayden, K. M., & Welsh-Bohmer, K. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_152 · Cited by 31
Haase, L., Wang, M., Green, E., & Murphy, C. (2011) · Human Brain Mapping · doi:10.1002/hbm.21451 · Cited by 22
Brinkmalm, A., Portelius, E., Brinkmalm, G., Pannee, J., Dahlén, R., Gobom, J., Blennow, K., & Zetterberg, H. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14594 · Cited by 23
Okadaic Acid and Hypoxia Induced Dementia Model of Alzheimer’s Type in Rats
Kaushal, A., Wani, W. Y., Bal, A., Gill, K. D., & Kaur, J. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0005-9 · Cited by 21
Arango‐Lasprilla, J. C., Iglesias, J., & Lopera, F. J. (2003) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750301800306 · Cited by 21
Voxel-Based Morphometry in Tau-Positive and Tau-Negative Frontotemporal Lobar Degenerations
Whitwell, J. L., Warren, J. D., Josephs, K. A., Godbolt, A. K., Révész, T., Fox, N. C., & Rossor, M. N. (2004) · Neurodegenerative Diseases · doi:10.1159/000080990 · Cited by 21
Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease
Riekkinen, M., Soininen, H. S., Riekkinen, P. J., Kuikka, J. T., Laakso, M. P., Helkala, E.-L., Partanen, J. V., & Riekkinen, P. J. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00400-4 · Cited by 21
Xu, W., Lopez-Guzman, M., Schoen, C. B., Fitzgerald, S. M., Lauer, S. L., Nixon, R. A., Levy, E., & Wilson, D. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106431 · Cited by 21
Modification of Tau by 8-Nitroguanosine 3′,5′-Cyclic Monophosphate (8-Nitro-cGMP)
Yoshitake, J., Soeda, Y., Ida, T., Sumioka, A., Yoshikawa, M., Matsushita, K., Akaike, T., & Takashima, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.734350 · Cited by 20
Classifying anatomical subtypes of subjective memory impairment
Kim, Y. J., Seo, S. W., Yoo, H., Yang, J., Park, S., Kim, Y. J., Lee, J. S., Lee, J. S., Jang, Y. K., Lee, J. M., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.010 · Cited by 20
Yener, G., Emek‐Savaş, D. D., Güntekin, B., & Başar, E. (2014) · Brain Research · doi:10.1016/j.brainres.2014.08.038 · Cited by 20
Riekkinen, P., Ikonen, S., & Riekkinen, M. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00068 · Cited by 20
The role of biological markers in the early and differential diagnosis of Alzheimer’s disease
Kurz, A., Riemenschneider, M. J., Drzezga, A. E., & Lautenschlager, N. T. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_13 · Cited by 20
The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
Ashford, J. W. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181198 · Cited by 19
Weis, S., Leube, D., Erb, M., Heun, R., Grodd, W., & Kircher, T. T. J. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.565892 · Cited by 19
Liu, Z., Kameshima, N., Nanjo, T., Shiino, A., Kato, T., Shimizu, S., Shimizu, T., Tanaka, S., Miura, K., & Tooyama, I. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170962 · Cited by 19
Metadata
- Authors
- Braak, H., & Braak, E.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Braak, H.
- ORCID
- Braak, H.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Wiley
- Published
- 1996-04
- Volume
- 94
- Issue
- S165
- Pages
- 3-12
- ISSN
- 0001-6314 (ISSN-L)
- OpenAlex
- W1971744915
- Cited by
- 710
- References
- 53
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 27 · 2023: 22 · 2022: 29 · 2021: 22 · 2020: 29 · 2019: 27 · 2018: 29 · 2017: 25 · 2016: 31 · 2015: 36 · 2014: 36 · 2013: 31 · 2012: 36
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Neurologica Scandinavica (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neuropathology, amyloid plaques, tau protein, neurofibrillary tangles, entorhinal cortex, cortical atrophy, disease stage, etiopathogenesis
- MeSH terms
- Alzheimer Disease, Hippocampus, Humans, Neurofibrillary Tangles, Entorhinal Cortex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review